EndoGastric Solutions Company
EndoGastric Solutions, Inc. (www.endogastricsolutions.com), is a medical device company developing and commercializing innovative, evidence-based, incisionless surgical technology for the treatment of GERD. EGS has combined the most advanced concepts in gastroenterology and surgery to develop the Transoral Incisionless Fundoplication (TIF®) 2.0 procedure—a minimally invasive solution that addresses a significant unmet clinical need. EndoGastric Solutions, Inc. was founded in 2003 and is headquartered in Redmond, Washington.
Technology:
P4 Medicine
Industry:
Health Care, Health Diagnostics, Medical Device
Headquarters:
San Mateo, California, United States
Founded Date:
2003-05-01
Employees Number:
51-100
Funding Status:
Late Stage Venture
Investors Number:
12
Total Funding:
$335.2M
Estimated Revenue:
$10M to $50M
Last Funding Type:
Series I
Register and Claim Ownership